Ripple Therapeutics is a Great Place to Work

TORONTO, ON, CANADA / JUNE 20, 2022 - Ripple Therapeutics is pleased to announce that we have been certified as a Great Place to Work® after a thorough, independent analysis conducted by Great Place to Work Institute® Canada. This certification is based on direct feedback from employees, provided as part of an extensive and anonymous survey about their workplace experience. 


“Having a culture that helps us to attract, develop and retain top talent has always been a critical success factor at Ripple Therapeutics”, commented Tom Reeves, President & CEO.  “Our corporate values emphasize that we care, we collaborate and we have fun while persevering to find innovative solutions to complex problems.  We want to make sure that Ripple is a great place to work so it’s fantastic to receive this independent third-party validation.”


Nancy Fonseca, Senior Vice President of Great Place to Work® Canada, says that a great workplace is about the level of trust that employees experience in their leaders, the level of pride they have in their jobs, and the extent to which they enjoy their colleagues. "Our data shows that great workplaces benefit from stronger financial performance, reduced turnover, and better customer satisfaction than their peers. What's more, work environments with trust at the foundation are ripe for innovation, agility, resilience and efficiency," Fonseca said.

About Ripple Therapeutics

Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery.  The core feature of Ripple’s Epidel™ technology is the ability to engineer sustained-release pharmaceuticals with zero-order release kinetics without the use of polymers or excipients.  Ripple has a full product pipeline in development. www.rippletherapeutics.com

About Great Place to Work®

Great Place to Work is the global authority on high-trust, high-performance workplace cultures. Through proprietary assessment tools, advisory services, and certification programs, Great Place to Work recognizes Canada’s Best Workplaces in a series of national lists including those published by The Globe & Mail (Canada) and Fortune magazine (USA). Great Place to Work provides the benchmarks, framework, and expertise needed to create, sustain, and recognize outstanding workplace cultures. Visit us at www.greatplacetowork.ca or find us on Twitter at @GPTW_Canada.

Media Contact

Julie Fotheringham, V.P. Marketing, People & Culture

RIPPLE-ABBVIE OPHTHALMIC DRUG DELIVERY PANEL

February 12, 2026
Our Chief Technology Officer, Wendy Naimark , was pleased to be speaking with AbbVie Directors, Allison Hoch, PhD, MBA, Director of Global Alliances and Amy Hopkin Director of Search & Evaluation for AbbVie Eyecare, on a Harnessing Innovation & Collaboration to Accelerate Ophthalmic Drug Delivery Panel at the 4th Annual Ophthalmic Drug Delivery Summit on Thursday January 29th in San Francisco, CA. 🗣️ Topic: Unlocking Biotech-Pharma Collaboration: How Agile Small Teams & Experienced Pharma Combine Strengths to Accelerate Innovation & Deliver Real-World Impact. Areas Covered: ✅ Co-developing platforms, managing device timelines and regulatory alignment in combo products ✅ Leveraging the speed and innovation of biotech startups with deep experience and resources of pharma ✅ Continuous learning through cooperation during diligence, development planning and execution phases ✅ The importance of proactive, transparent communication across functions to anticipate challenges and optimize for success View Presentation

Ripple Therapeutics Enters Collaboration with Bausch + Lomb

November 25, 2025
TORONTO, CANADA / November 25, 2025 - Ripple Therapeutics Corporation, a clinical stage company focused on improving ophthalmic therapeutics with controllable sustained delivery implants, is pleased to announce that, earlier this year, it entered into an evaluation program and licensing option agreement with an affiliate of Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better.